149 related articles for article (PubMed ID: 27063105)
1. Multiple sclerosis: Vitamin D deficiency leads to excessive B-cell responses in multiple sclerosis.
Fyfe I
Nat Rev Neurol; 2016 May; 12(5):252. PubMed ID: 27063105
[No Abstract] [Full Text] [Related]
2. Hypovitaminosis D upscales B-cell immunoreactivity in multiple sclerosis.
Haas J; Schwarz A; Korporal-Kuhnke M; Faller S; Jarius S; Wildemann B
J Neuroimmunol; 2016 May; 294():18-26. PubMed ID: 27138094
[TBL] [Abstract][Full Text] [Related]
3. Comment on "Gender differences in 1,25 dihydroxyvitamin D3 immunomodulatory effects in multiple sclerosis patients and healthy subjects".
Handel AE; De Luca GC; Ramagopalan SV
J Immunol; 2011 Jan; 186(2):647; author reply 648. PubMed ID: 21209286
[No Abstract] [Full Text] [Related]
4. Immunomodulatory effects of Vitamin D in multiple sclerosis.
Correale J; Ysrraelit MC; Gaitán MI
Brain; 2009 May; 132(Pt 5):1146-60. PubMed ID: 19321461
[TBL] [Abstract][Full Text] [Related]
5. Effect of vitamin D replacement on immunological biomarkers in patients with multiple sclerosis.
Mrad MF; El Ayoubi NK; Esmerian MO; Kazan JM; Khoury SJ
Clin Immunol; 2017 Aug; 181():9-15. PubMed ID: 28536054
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D in MS: a vitamin for 4 seasons.
Ascherio A; Marrie RA
Neurology; 2012 Jul; 79(3):208-10. PubMed ID: 22700805
[No Abstract] [Full Text] [Related]
7. Effect of vitamin D replacement on depression in multiple sclerosis patients.
Kotb MA; Kamal AM; Aldossary NM; Bedewi MA
Mult Scler Relat Disord; 2019 Apr; 29():111-117. PubMed ID: 30708308
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of vitamin D3 as add-on therapy in patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon β-1a: a Phase II, multicenter, double-blind, randomized, placebo-controlled trial.
Smolders J; Hupperts R; Barkhof F; Grimaldi LM; Holmoy T; Killestein J; Rieckmann P; Schluep M; Vieth R; Hostalek U; Ghazi-Visser L; Beelke M;
J Neurol Sci; 2011 Dec; 311(1-2):44-9. PubMed ID: 21620416
[TBL] [Abstract][Full Text] [Related]
9. Multiple sclerosis in a patient with membranous glomerulopathy: is vitamin D deficiency the culprit in the presence of HLA DRB1*1501 allele?
Sivaramakrishnan R; Kaul B; Jain SB; Mandonca S; Gupta S
Mult Scler; 2011 Feb; 17(2):254. PubMed ID: 20876154
[No Abstract] [Full Text] [Related]
10. Bone metabolism and vitamin D status in patients with multiple sclerosis.
Kępczyńska K; Zajda M; Lewandowski Z; Przedlacki J; Zakrzewska-Pniewska B
Neurol Neurochir Pol; 2016; 50(4):251-7. PubMed ID: 27375138
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D-mediated immune regulation in multiple sclerosis.
Correale J; Ysrraelit MC; Gaitán MI
J Neurol Sci; 2011 Dec; 311(1-2):23-31. PubMed ID: 21723567
[TBL] [Abstract][Full Text] [Related]
12. IFN-β therapy modulates B-cell and monocyte crosstalk via TLR7 in multiple sclerosis patients.
Giacomini E; Severa M; Rizzo F; Mechelli R; Annibali V; Ristori G; Riccieri V; Salvetti M; Coccia EM
Eur J Immunol; 2013 Jul; 43(7):1963-72. PubMed ID: 23636665
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D is associated with degree of disability in patients with fully ambulatory relapsing-remitting multiple sclerosis.
Thouvenot E; Orsini M; Daures JP; Camu W
Eur J Neurol; 2015 Mar; 22(3):564-9. PubMed ID: 25530281
[TBL] [Abstract][Full Text] [Related]
14. Response to the letter by Bolland et al on defining vitamin D deficiency.
Livesey J; Elder P; Ellis MJ; Florkowski C; McKenzie R; Liley B
N Z Med J; 2007 Nov; 120(1265):U2815. PubMed ID: 18264191
[No Abstract] [Full Text] [Related]
15. Effective suppression of cerebrospinal fluid B cells by rituximab and cyclophosphamide in progressive multiple sclerosis.
Petereit HF; Rubbert A
Arch Neurol; 2005 Oct; 62(10):1641-2; author reply 1642. PubMed ID: 16216954
[No Abstract] [Full Text] [Related]
16. Immune regulatory effects of high dose vitamin D
Muris AH; Smolders J; Rolf L; Thewissen M; Hupperts R; Damoiseaux J;
J Neuroimmunol; 2016 Nov; 300():47-56. PubMed ID: 27806875
[TBL] [Abstract][Full Text] [Related]
17. Physical activity in multiple sclerosis: a comparative study of vitamin D, brain-derived neurotrophic factor and regulatory T cell populations.
Waschbisch A; Wenny I; Tallner A; Schwab S; Pfeifer K; Mäurer M
Eur Neurol; 2012; 68(2):122-8. PubMed ID: 22832849
[TBL] [Abstract][Full Text] [Related]
18. [Impact of vitamin D in neurological diseases and neurorehabilitation: from dementia to multiple sclerosis. Part I: the role of vitamin D in the prevention and treatment of multiple sclerosis].
Speer G
Ideggyogy Sz; 2013 Sep; 66(9-10):293-303. PubMed ID: 24358684
[TBL] [Abstract][Full Text] [Related]
19. Cannabinoids and B cells: emerging targets for treating progressive multiple sclerosis.
Giovannoni G
Mult Scler; 2011 Mar; 17(3):259-61. PubMed ID: 21362756
[No Abstract] [Full Text] [Related]
20. Alemtuzumab (Compath) off-label for relapsing multiple sclerosis.
Med Lett Drugs Ther; 2009 Mar; 51(1307):17-8. PubMed ID: 19265776
[No Abstract] [Full Text] [Related]
[Next] [New Search]
